Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 14, 2023
8-k 8K-related 16 Dec 12, 2023
8-k 8K-related 15 Dec 08, 2023
8-k 8K-related 14 Dec 06, 2023
8-k 8K-related 70 Nov 28, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.